The Open Bioactive Compounds Journal




ISSN: 1874-8473 ― Volume 7, 2019

Cytokine-Modulatory Activity and Therapeutic Efficacy of 7-Amino-4-Methylcoumarin in Murine Collagen-Induced Arthritis



Masahiko Kurokawaa, *, Masami Imakitab, Kimiyasu Shirakic
a Department of Biochemistry, School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, 1714-1 Yoshino, Nobeoka, Miyazaki 882-8508, Japan,
b Department of Pathology, Rinku General Medical Center, Izumisano, Osaka, 598-8577 Japan,
c Department of Virology, University of Toyama, 2630 Sugitani, Toyama 930-0194, Japan

Abstract

7-Amino-4-methylcoumarin (AMC) was previously shown to suppress pro-inflammatory cytokine production and prevent death in an endotoxic shock model in mice. In the present study, we investigated the effectiveness of AMC as a potential cytokine modulator in alleviating autoimmune diseases. We examined the efficacy and cytokine-modulatory activity of AMC in collagen-induced arthritis (CIA) in mice. Mice were immunized with type II collagen. AMC at 0, 3, or 30 mg/kg was administered orally to the immunized mice once daily for three weeks before and/or three times daily for two weeks after the onset of CIA. The development of arthritis of the paws and cytokine levels in serum were examined. AMC significantly reduced the incidence and severity of CIA prophylactically and therapeutically, and suppressed the rise of systemic interleukin-6 and interferon-γ (levels to the basal levels in the early phase of CIA. AMC also significantly suppressed the level of tumor necrosis factor-α in the severe phase of CIA. However, the levels of interleukin-10 and anti-collagen antibody were not affected by AMC. In the early phase of CIA, the suppression of interleukin-6 and interferon-γ (levels by AMC correlated with the amelioration of symptoms of CIA in a dose-dependent manner. AMC may inhibit the onset of cytokine-mediated disease rather than suppressing disease progression without toxicity or affecting anti-collagen antibody production. AMC was significantly effective against CIA in mice and confirmed to possess cytokine-modulatory activity in vivo. The results suggest that AMC is a potential therapeutic agent for autoimmune diseases.

Keywords: Collagen-induced arthritis, 7-amino-4-methylcoumarin, cytokines.


Article Information


Identifiers and Pagination:

Year: 2010
Volume: 3
First Page: 12
Last Page: 17
Publisher Id: TOBCJ-3-12
DOI: 10.2174/1874847301003010012

Article History:

Received Date: 1/10/2009
Revision Received Date: 3/11/2009
Acceptance Date: 22/2/2010
Electronic publication date: 20/08/2010
Collection year: 2010

Article Metrics:

CrossRef Citations:
0

Total Statistics:

Full-Text HTML Views: 864
Abstract HTML Views: 797
PDF Downloads: 301
ePub Downloads: 117
Total Views/Downloads: 2079

Unique Statistics:

Full-Text HTML Views: 524
Abstract HTML Views: 487
PDF Downloads: 184
ePub Downloads: 93
Total Views/Downloads: 1288
Geographical View

© Kurokawa et al.; Licensee Bentham Open.

open-access license: This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http: //creativecommons.org/licenses/by-nc/3.0/ which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.


* Address correspondence to this author at Department of Biochemistry, School of Pharmaceutical Sciences, Kyushu University of Health and Welfare, 1714-1 Yoshino, Nobeoka, Miyazaki 882-8508, Japan; Tel: +81-982-23-5574; Fax: +81-982-23-5684; E-mail: b2mk@phoenix.ac.jp



Endorsements



"It is an honor for us to publish our article in Open bioactive compound journal. The journal follows single blind peer review and plagiarism checking policy which is appreciable. I think soon your journal will attain high impact factor journals."


Zubair K. Labu
Department of Pharmacy, World University of Bangladesh, Bangladesh


Browse Contents



Webmaster Contact: info@benthamopen.net
Copyright © 2019 Bentham Open